coronary heart disease
CRN Responds to Cholesterol Study That Compares Supplements to Prescription Drug
The Council for Responsible Nutrition (CRN) has responded to results of the “Supplements, Placebo, or Rosuvastatin (SPORT)” Study. It was presented at the American Heart Association Scientific Sessions Nov. 6 and published in the Journal of the American College of Cardiology. SPORT, funded by AstraZeneca, the company that markets Rosuvastatin, compared the effect on low-density ...
Study Finds EPA and DHA Lower Risk of Coronary Heart Disease
EPA and DHA omega-3s reduce the risk of coronary heart disease (CHD), according to results of a new, comprehensive meta-analysis published in the Mayo Clinic Proceedings and sponsored by the Global Organization for EPA and DHA Omega-3s (GOED). Among randomized controlled trials (RCTs), there was a statistically significant reduction in CHD risk in higher risk populations, including: ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Vitamin Retailer magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.
Featured Listing:
Subscribe To Our Newsletter
Stay Informed! Breaking news, industry trends featured topics, and more.
Subscribe to our newsletter today!